Cargando…
SARS-CoV-2 transmission across age groups in France and implications for control
The shielding of older individuals has been proposed to limit COVID-19 hospitalizations while relaxing general social distancing in the absence of vaccines. Evaluating such approaches requires a deep understanding of transmission dynamics across ages. Here, we use detailed age-specific case and hosp...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617041/ https://www.ncbi.nlm.nih.gov/pubmed/34824245 http://dx.doi.org/10.1038/s41467-021-27163-1 |
_version_ | 1784604459512365056 |
---|---|
author | Tran Kiem, Cécile Bosetti, Paolo Paireau, Juliette Crépey, Pascal Salje, Henrik Lefrancq, Noémie Fontanet, Arnaud Benamouzig, Daniel Boëlle, Pierre-Yves Desenclos, Jean-Claude Opatowski, Lulla Cauchemez, Simon |
author_facet | Tran Kiem, Cécile Bosetti, Paolo Paireau, Juliette Crépey, Pascal Salje, Henrik Lefrancq, Noémie Fontanet, Arnaud Benamouzig, Daniel Boëlle, Pierre-Yves Desenclos, Jean-Claude Opatowski, Lulla Cauchemez, Simon |
author_sort | Tran Kiem, Cécile |
collection | PubMed |
description | The shielding of older individuals has been proposed to limit COVID-19 hospitalizations while relaxing general social distancing in the absence of vaccines. Evaluating such approaches requires a deep understanding of transmission dynamics across ages. Here, we use detailed age-specific case and hospitalization data to model the rebound in the French epidemic in summer 2020, characterize age-specific transmission dynamics and critically evaluate different age-targeted intervention measures in the absence of vaccines. We find that while the rebound started in young adults, it reached individuals aged ≥80 y.o. after 4 weeks, despite substantial contact reductions, indicating substantial transmission flows across ages. We derive the contribution of each age group to transmission. While shielding older individuals reduces mortality, it is insufficient to allow major relaxations of social distancing. When the epidemic remains manageable (R close to 1), targeting those most contributing to transmission is better than shielding at-risk individuals. Pandemic control requires an effort from all age groups. |
format | Online Article Text |
id | pubmed-8617041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-86170412021-12-10 SARS-CoV-2 transmission across age groups in France and implications for control Tran Kiem, Cécile Bosetti, Paolo Paireau, Juliette Crépey, Pascal Salje, Henrik Lefrancq, Noémie Fontanet, Arnaud Benamouzig, Daniel Boëlle, Pierre-Yves Desenclos, Jean-Claude Opatowski, Lulla Cauchemez, Simon Nat Commun Article The shielding of older individuals has been proposed to limit COVID-19 hospitalizations while relaxing general social distancing in the absence of vaccines. Evaluating such approaches requires a deep understanding of transmission dynamics across ages. Here, we use detailed age-specific case and hospitalization data to model the rebound in the French epidemic in summer 2020, characterize age-specific transmission dynamics and critically evaluate different age-targeted intervention measures in the absence of vaccines. We find that while the rebound started in young adults, it reached individuals aged ≥80 y.o. after 4 weeks, despite substantial contact reductions, indicating substantial transmission flows across ages. We derive the contribution of each age group to transmission. While shielding older individuals reduces mortality, it is insufficient to allow major relaxations of social distancing. When the epidemic remains manageable (R close to 1), targeting those most contributing to transmission is better than shielding at-risk individuals. Pandemic control requires an effort from all age groups. Nature Publishing Group UK 2021-11-25 /pmc/articles/PMC8617041/ /pubmed/34824245 http://dx.doi.org/10.1038/s41467-021-27163-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Tran Kiem, Cécile Bosetti, Paolo Paireau, Juliette Crépey, Pascal Salje, Henrik Lefrancq, Noémie Fontanet, Arnaud Benamouzig, Daniel Boëlle, Pierre-Yves Desenclos, Jean-Claude Opatowski, Lulla Cauchemez, Simon SARS-CoV-2 transmission across age groups in France and implications for control |
title | SARS-CoV-2 transmission across age groups in France and implications for control |
title_full | SARS-CoV-2 transmission across age groups in France and implications for control |
title_fullStr | SARS-CoV-2 transmission across age groups in France and implications for control |
title_full_unstemmed | SARS-CoV-2 transmission across age groups in France and implications for control |
title_short | SARS-CoV-2 transmission across age groups in France and implications for control |
title_sort | sars-cov-2 transmission across age groups in france and implications for control |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617041/ https://www.ncbi.nlm.nih.gov/pubmed/34824245 http://dx.doi.org/10.1038/s41467-021-27163-1 |
work_keys_str_mv | AT trankiemcecile sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT bosettipaolo sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT paireaujuliette sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT crepeypascal sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT saljehenrik sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT lefrancqnoemie sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT fontanetarnaud sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT benamouzigdaniel sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT boellepierreyves sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT desenclosjeanclaude sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT opatowskilulla sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol AT cauchemezsimon sarscov2transmissionacrossagegroupsinfranceandimplicationsforcontrol |